JP2008505078A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008505078A5 JP2008505078A5 JP2007519301A JP2007519301A JP2008505078A5 JP 2008505078 A5 JP2008505078 A5 JP 2008505078A5 JP 2007519301 A JP2007519301 A JP 2007519301A JP 2007519301 A JP2007519301 A JP 2007519301A JP 2008505078 A5 JP2008505078 A5 JP 2008505078A5
- Authority
- JP
- Japan
- Prior art keywords
- diffraction pattern
- ray powder
- group
- powder diffraction
- alpha radiation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US58375704P | 2004-06-29 | 2004-06-29 | |
| US60/583,757 | 2004-06-29 | ||
| PCT/US2005/022408 WO2006016995A1 (en) | 2004-06-29 | 2005-06-22 | Crystal forms of (3r)-1-(2-methylalanyl-d-tryptophyl)-3-(phenylmethyl)-3-piperidinecarboxylic acid 1,2,2-trimethylhydrazide |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012134975A Division JP5718286B2 (ja) | 2004-06-29 | 2012-06-14 | （３ｒ）−１−（２−メチルアラニル−ｄ−トリプトフィル）−３−（フェニルメチル）−３−ピペリジンカルボン酸１，２，２−トリメチルヒドラジドの結晶形 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2008505078A JP2008505078A (ja) | 2008-02-21 |
| JP2008505078A5 true JP2008505078A5 (https=) | 2008-07-17 |
| JP5122950B2 JP5122950B2 (ja) | 2013-01-16 |
Family
ID=35064648
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007519301A Expired - Lifetime JP5122950B2 (ja) | 2004-06-29 | 2005-06-22 | （３ｒ）−１−（２−メチルアラニル−ｄ−トリプトフィル）−３−（フェニルメチル）−３−ピペリジンカルボン酸１，２，２−トリメチルヒドラジドの結晶形 |
| JP2012134975A Expired - Lifetime JP5718286B2 (ja) | 2004-06-29 | 2012-06-14 | （３ｒ）−１−（２−メチルアラニル−ｄ−トリプトフィル）−３−（フェニルメチル）−３−ピペリジンカルボン酸１，２，２−トリメチルヒドラジドの結晶形 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012134975A Expired - Lifetime JP5718286B2 (ja) | 2004-06-29 | 2012-06-14 | （３ｒ）−１−（２−メチルアラニル−ｄ−トリプトフィル）−３−（フェニルメチル）−３−ピペリジンカルボン酸１，２，２−トリメチルヒドラジドの結晶形 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US7825138B2 (https=) |
| EP (2) | EP2298760B1 (https=) |
| JP (2) | JP5122950B2 (https=) |
| KR (1) | KR101324340B1 (https=) |
| CN (3) | CN1976921B (https=) |
| CA (1) | CA2572325C (https=) |
| IL (1) | IL180336A0 (https=) |
| MX (1) | MXPA06015003A (https=) |
| WO (1) | WO2006016995A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1976921B (zh) * | 2004-06-29 | 2013-08-21 | 蓝宝石治疗公司 | (3r)-1-(2-甲基丙氨酰-d-色氨酰)-3-(苯甲基)-3-哌啶羧酸1,2,2-三甲基酰肼的晶形 |
| US20130281701A1 (en) * | 2004-06-29 | 2013-10-24 | Helsinn Therapeutics (U.S.), Inc. | Crystal forms of anamorelin |
| JO3353B1 (ar) | 2012-04-20 | 2019-03-13 | Ono Pharmaceutical Co | شكل صلب معزول من أحادي هيدروكلوريد أناموريلين بنسبة مولارية منخفضة من الكلوريد: أناموريلين ومحتوى منخفض من مذيب عضوي متبقي |
| SI2958916T1 (sl) * | 2013-02-21 | 2018-11-30 | Pfizer Inc. | Trdne oblike selektivnih zaviralcev CDK4/6 |
| GEP20186939B (en) * | 2014-09-04 | 2018-12-25 | Healthcare Sa Helsinn | Medical treatments based on anamorelin |
| WO2017067438A1 (zh) * | 2015-10-20 | 2017-04-27 | 江苏恒瑞医药股份有限公司 | 一种阿拉莫林的结晶形式及其制备方法 |
| US9837965B1 (en) | 2016-09-16 | 2017-12-05 | Peregrine Semiconductor Corporation | Standby voltage condition for fast RF amplifier bias recovery |
| BR112022002767A2 (pt) | 2019-08-30 | 2022-05-10 | Helsinn Healthcare Sa | Métodos de fabricação de um comprimido de cloridrato de anamorelina, comprimidos e método para melhorar um ou mais sintomas de caquexia de câncer |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL322706A1 (en) * | 1993-11-09 | 1998-02-16 | Merck & Co Inc | Piperidines, pyrolidines and hexahydro-1h-azepins enhancing growth hormone liberation |
| WO1998003473A1 (en) * | 1996-07-22 | 1998-01-29 | Novo Nordisk A/S | Compounds with growth hormone releasing properties |
| IL137007A0 (en) * | 1998-01-16 | 2001-06-14 | Novo Nordisk As | Compounds with growth hormone releasing properties |
| US6303620B1 (en) * | 1998-05-11 | 2001-10-16 | Novo Nordisk A/S | Compounds with growth hormone releasing properties |
| PT1077941E (pt) * | 1998-05-11 | 2010-07-01 | Novo Nordisk As | Compostos com propriedades de libertaão da hormona de crescimento |
| ID29137A (id) * | 1998-07-27 | 2001-08-02 | Schering Corp | Ligan-ligan afinitas tinggi untuk reseptor nosiseptin orl-1 |
| UA73530C2 (uk) * | 1999-11-10 | 2005-08-15 | Ново Нордіск А/С | Сполука з властивостями вивільнювати гормон росту |
| KR20070010151A (ko) * | 2004-03-30 | 2007-01-22 | 사파이어 세라퓨틱스, 인크. | 성장 호르몬 분비촉진제를 이용하여 ｃ-반응성 단백질을감소시키는 방법 |
| CN1976921B (zh) * | 2004-06-29 | 2013-08-21 | 蓝宝石治疗公司 | (3r)-1-(2-甲基丙氨酰-d-色氨酰)-3-(苯甲基)-3-哌啶羧酸1,2,2-三甲基酰肼的晶形 |
-
2005
- 2005-06-22 CN CN2005800215163A patent/CN1976921B/zh not_active Expired - Lifetime
- 2005-06-22 CN CN201110251236.9A patent/CN102584937B/zh not_active Expired - Lifetime
- 2005-06-22 CN CN201310308801.XA patent/CN103772483A/zh active Pending
- 2005-06-22 JP JP2007519301A patent/JP5122950B2/ja not_active Expired - Lifetime
- 2005-06-22 KR KR1020067026722A patent/KR101324340B1/ko not_active Expired - Lifetime
- 2005-06-22 WO PCT/US2005/022408 patent/WO2006016995A1/en not_active Ceased
- 2005-06-22 MX MXPA06015003A patent/MXPA06015003A/es active IP Right Grant
- 2005-06-22 EP EP10185517.9A patent/EP2298760B1/en not_active Expired - Lifetime
- 2005-06-22 US US11/165,598 patent/US7825138B2/en active Active
- 2005-06-22 CA CA2572325A patent/CA2572325C/en not_active Expired - Lifetime
- 2005-06-22 EP EP05766869.1A patent/EP1768976B1/en not_active Expired - Lifetime
-
2006
- 2006-12-26 IL IL180336A patent/IL180336A0/en unknown
-
2010
- 2010-07-06 US US12/831,009 patent/US8466173B2/en not_active Expired - Lifetime
-
2012
- 2012-06-14 JP JP2012134975A patent/JP5718286B2/ja not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI358296B (en) | Acid secretion inhibitor | |
| JP5638515B2 (ja) | ピロール化合物 | |
| JP4931874B2 (ja) | リモナバントの結晶多形の製造方法 | |
| TWI853027B (zh) | N-[4-(氯二氟甲氧基)苯基]-6-[(3r)-3-羥基吡咯啶-1-基]-5-(1h-吡唑-5-基)吡啶-3-甲醯胺之結晶形狀 | |
| TW201011003A (en) | Triazole compounds that modulate HSP90 activity | |
| TW201734012A (zh) | 經取代２－苯基－３－（哌甲基）咪唑并吡啶類及其用途 | |
| TW200900064A (en) | Pyrrole compounds | |
| TW200932249A (en) | Combination therapy comprising SGLT inhibitors and DPP4 inhibitors | |
| TW201202217A (en) | 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amion]-propionic acid ethylester-methanesulfonate and its use as a medicament | |
| JP2001522780A (ja) | オメプラゾールの新規な結晶形 | |
| DE60103375T2 (de) | 1,3-dihydro-2h-indol-2-on derivate und deren verwendung als liganden der arginin-vasopressin-rezeptoren v1b oder v1b und v1a | |
| TW200823185A (en) | Sulfonamide derivatives | |
| TW202200594A (zh) | 一種glp-1受體激動劑的晶型a及其製備方法 | |
| CN1290843C (zh) | 4－[2－[4－[1－(2－乙氧基乙基)－1H－苯并咪唑－2－基]－1－哌啶基]乙基]－α,α－二甲基苯乙酸的多晶型物 | |
| JP2008505078A5 (https=) | ||
| WO1992017473A1 (en) | Crystalline tiagabine hydrochloride monohydrate, its preparation and use | |
| CN1984905B (zh) | 作为凝血酶受体拮抗剂的约束喜巴辛类似物 | |
| JPH11502230A (ja) | インダゾールカルボキサミド類 | |
| CN102844301A (zh) | 新苯甲酰胺衍生物 | |
| TWI488850B (zh) | 經二取代之[４－（５－胺基甲基－苯基）－哌啶－１－基]－[１ｈ－吲哚－３－基]－甲酮 | |
| ES2617657T3 (es) | Derivado de metastina y uso del mismo | |
| US20080234323A1 (en) | Amorphous and Three Crystalline Forms of Rimonabant Hydrochloride | |
| JP2007504223A5 (https=) | ||
| TW200922586A (en) | Thiophene 1,2,4-triazole derivatives as modulators of mGluR5 | |
| CN1222510C (zh) | 苯甲酰基胍盐 |